Dupilumab treatment is associated with improvement of refractory eosinophilic fasciitis: A single center retrospective study. // Journal of the American Academy of Dermatology. – URL: https://www.sciencedirect.com/science/article/pii/S019096222603968X?dgcid=rss_sd_all
Dupilumab treatment is associated with improvement of refractory eosinophilic fasciitis: A single center retrospective study. Journal of the American Academy of Dermatology. https://www.sciencedirect.com/science/article/pii/S019096222603968X?dgcid=rss_sd_all
“Dupilumab treatment is associated with improvement of refractory eosinophilic fasciitis: A single center retrospective study.” Journal of the American Academy of Dermatology.
@article{article55603,
title = {Dupilumab treatment is associated with improvement of refractory eosinophilic fasciitis: A single center retrospective study},
journal = {Journal of the American Academy of Dermatology},
url = {https://www.sciencedirect.com/science/article/pii/S019096222603968X?dgcid=rss_sd_all}
}